Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine and Naltrexone for Alcohol Drinking Behaviors
NCT01519063Phase 2Completed
- Sponsor
- Yale University
- Start
- Jan 2012
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of memantine in alcohol use disorder (AUD), sponsored by Yale University. Started Jan 2012; status: completed.
02
Drugs
memantine
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT01519063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01519063.